Press release on the financial results for the half year and year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
EP Biocomposites Limited reported strong FY26 results with revenue growing 13.6% YoY to Rs. 1,200.62 lakh. EBITDA surged 26.23% to Rs. 237.83 lakh with margins expanding from 15.69% to 17.44%. PAT jumped 41.47% to Rs. 145.83 lakh, translating to EPS of Rs. 8.67 vs Rs. 6.13 in FY25. The company strengthened its balance sheet through partial debt repayment, with net worth crossing Rs. 12 crore and ROCE improving to 16%. IPO proceeds were deployed towards capacity expansion and working capital. Management remains optimistic about future growth opportunities.
Strong profitability growth with margin expansion signals operational efficiency gains. The company's improving balance sheet and debt reduction enhance financial stability, which could be positive for the stock.